Bharat Biotech asked to submit complete phase-2 data of its COVID-19 vaccine before phase-3 trial

Bharat Biotech asked to submit complete phase-2 data of its COVID-19 vaccine before phase-3 trial

Hindu

Published

According to officials, Bharat Biotech applied to the DCGI on Oct. 2, seeking its permission to conduct phase-3 randomised double-blind placebo-controlled multicentre trial of its COVID-19 vaccine candidate

Full Article